Breakthrough in Alzheimer’s Research

Introduction to the Disease

Recent studies have shown that new antibody drugs can slow cognitive decline in people with early-onset Alzheimer’s disease, a crucial finding considering there is currently no cure for the disease.

Ongoing Research and Clinical Trials

The clinical trials involve 1 to 2 percent of people with Alzheimer’s who have a genetic predisposition to developing dementia. This research is being conducted at institutions such as Washington University School of Medicine in St. Louis, which is at the forefront of treating the disease before symptoms appear.

Support for Alzheimer’s Research

Philanthropic efforts are also playing a significant role in advancing our understanding and treatment of Alzheimer’s. Notable contributions have been made to support research, with donations totaling $300 million to date, highlighting the importance of continued funding to combat this disease.